The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

Following a recent trial, doctors at The Christie Hospital are optimistic about the study of HMBD-001 in the treatment of ...

Innovent has submitted a second new drug application (NDA) to China's National Medical Products Administration (NMPA) seeking approval for Dovbleron as a treatment for ROS1-positive advanced NSCLC ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

IND submission for intranasal SPC-15 treatment expected in 2025; Phase 1 clinical trial to follow upon approvalSP-26 ketamine implants nearing ...

Shares of Viking Therapeutics VKTX have lost nearly 22% in the past six months, significantly underperforming the industry’s ...

Pharmaceuticals for the development of a potential. “We are pleased to partner with Amylyx to advance GLP-1 receptor antagonism research. This collaboration and development agreement is an example of ...

The agreement entails identifying a lead development candidate following a screening period for entry into Investigational New Drug (“IND”)-enabling studies. Once the long-acting GLP-1 receptor ...

From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...

Neurizon, a clinical-stage biotech company advancing treatments for neurodegenerative diseases, has announced the filing of an Investigational New Drug (IND) application to the US Food and Drug ...